Cruciate Ligament Diagnosis & Treatment Market Research Report: Injury Type (Grade I, II, III), Product (Cement Implants, Cement-Less Implants), Indication (Osteoarthritis, RA), Treatment (Surgery), End-User (Hospitals, ASCs) - Forecast Till 2030

Cruciate Ligament Diagnosis & Treatment Market Scenario

The Cruciate Ligament Diagnosis & Treatment Market is projected to reach USD 9.2 Billion by 2030 at 9.40% CAGR during the forecast period 2022-2030

Numerous other factors such as growing number of knee reconstruction surgeries, increase in aging population coupled with rising incidences of diseases related to age such as rheumatoid arthritis and osteoarthritis, and increasing government assistance are continuously contributing to the growth of the cruciate ligament diagnosis and treatment market.

Despite these drivers, there are some issues associated with the cruciate ligament diagnosis and treatment market. The complications associated with the treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.

• Primary Research

The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

• Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the cruciate ligament diagnosis and treatment market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and treatment perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Key Players

Some of the key players in the cruciate ligament diagnosis & treatment market are Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others.

Segmentation

The cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.

Based on type, the cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).

The segments for injury type for the cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.

On the basis of product, the cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.

Based on indication, the cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.

The diagnosis segment for the cruciate ligament diagnosis and treatment market is classified as imaging others. The imaging segment is further classified as Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, and others.

Based on treatment, the cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.

On the basis of end-user, the cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Centers (ASC), and others.

Geographically, the global market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The European market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the Rest of Western Europe.

The Asia Pacific market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.

The Middle Eastern and African market is segmented into the Middle East and Africa.

Regional Market Summary

Cruciate Ligament Diagnosis & Treatment Market, by Region Market Share, 2017 (%)

Source: MRFR Analysis

The Americas dominates the cruciate ligament diagnosis and treatment market owing to the rising prevalence of osteoarthritis among the elderly population, well-developed surgical technology, high healthcare expenditure, and the presence of the leading players.

This market is attracting many key participants such as Stryker Corporation; Zimmer Biomet; DePuySynthes, Inc., Arthrex, Inc.; Smith & Nephew plc; and CONMED Corporation. For instance, Smith & Nephew acquired the diversified product portfolio for orthopedic soft tissue repair from ArthroCare Corporation further strengthening the position of the company in the global market.

Europe holds the second position in the cruciate ligament diagnosis and treatment market. It is expected that the rising contribution towards research and development for the development of surgical implants and increasing competition among marketers for drug launch are likely to drive the European cruciate ligament diagnosis and treatment market. For instance, in May 2017 Ablynx, a biopharmaceutical company headquartered in Belgium, announced the completion of a preclinical package for a novel nanobody, ALX-1141 for the treatment of osteoarthritis. Merck will now be responsible for the further clinical development of the molecule.

Asia Pacific is the fastest growing cruciate ligament diagnosis and treatment market owing to a huge patient pool, increasing demand for treatments, and rising healthcare expenditure. For instance, in July 2017, Kolon Pharmaceutical got the approval for the World's first cell and gene therapy for knee osteoarthritis in Korea. Thus, all these factors are cumulatively responsible for the growth in this region.

The Middle East and Africa holds the lowest share of the global cruciate ligament diagnosis and treatment market due to low development, lack of technical knowledge, and poor medical facilities.

By type

• Posterior Cruciate Ligament (PCL)


• Anterior Cruciate Ligament (ACL)

By Injury type

• Grade I


• Grade II


• Grade III.

By Indication

• Osteoarthritis


• Rheumatoid arthritis


• Trauma

By Product

• Cemented implants


• Cement-less implants


• Partial implants


• Revision implants.

By Diagnosis

• Imaging


• Magnetic Resonance Imaging (MRI)’


• Ultrasound


• Laparoscopy


• Others

By Treatment

• Surgery


• Arthroscopy


• Anterior Cruciate Ligament (ACL) reconstruction


• Others


• Therapies


• Rehabilitation


• Physical Therapies


• Devices


• Elastic Bandages


• Others

By End-user

• Hospitals


• Orthopedic Clinics


• Ambulatory Surgical Center (ASC)

By Region

• 
  Americas
  
  
  
  • 
    North America
    
    
    
    • U.S.
    
    
    • Canada
    
    
    
    
  
  
  • South America
  
  
  
  


• 
  Europe
  
  
  
  • Western Europe
  
  
  • Germany
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • U.K.
  
  
  • Rest of Western Europe
  
  
  • Eastern Europe
  
  
  
  


• 
  Asia Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • Republic of Korea
  
  
  • Rest of Asia Pacific
  
  
  
  


• 
  The Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Company Profiles    

• Stryker Corporation


• Arthrex, Inc.


• Zimmer Biomet


• DePuy Synthes, Inc.


• CONMED Corporation


• Smith & Nephew plc.


• DJO Global Inc.


• Breg, Inc.


• Bauerfeind AG